While a comprehensive mechanism for the correlation between UCHL1 expression and overall survival of TNBC patients remains to be elucidated, UCHL1 could be a biomarker for breast cancer outcome or treatment decisions, particularly in ER− and TNBC [41]. The gene discussed is UCHL1; the disease is breast carcinoma.